Search Within

SMALL CELL LUNG CANCER
Results 1 - 261 of 261
Small-Cell Lung Cancer: Clinical Management and Unmet Needs New Perspectives for an Old Problem

Journal: Current Drug Targets
Volume: 18,Issue: 3
Page: 341-362
Authors: Giuseppe Lo Russo, Marianna Macerelli, Marco Platania, Nicoletta Zilembo, Milena Vitali, Diego Signorelli, Claudia Proto, Monica Ganzinelli, Rosaria Gallucci, Francesco Agustoni, Gianpiero Fasola, Filippo de Braud and Marina Chiara Garassino

Amrubicin: A Synthetic Anthracyclin Analogue in the Treatment of Extensive Stage Small Cell Lung Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4,Issue: 3
Page: 241-245
Authors: Chirag M. Shah

Autotaxin and Lysophosphatidic Acid Receptors as Novel Targets for the Radiosensitization of Tumor Vasculature in Non-Small Cell Lung Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 1,Issue: 1
Page: 72-80
Authors: Amanda G. Linkous, Dennis E. Hallahan and Eugenia M. Yazlovitskaya

Molecular and Clinical Analysis of Predictive Biomarkers in Non-Small-Cell Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 22
Page: 3689-3700
Authors: A. Passaro, A. Palazzo, P. Trenta, M. L. Mancini, F. Morano and E. Cortesi

Significant Changes in D2-like Dopamine Gene Receptors Expression Associated with Non- Small -Cell Lung Cancer: Could it be of Potential Use in the Design of Future Therapeutic Strategies?

Journal: Current Cancer Therapy Reviews
Volume: 8,Issue: 4
Page: 304-310
Authors: Mojhgan Shaikhpoor, Ghasem Ahangari, Majid Sadeghizadeh, Adnan Khosravi and Gholamreza Derakhshani Deilami

Therapeutic Vaccines Explored in Patients with Non-Small Cell Lung Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 2
Page: 256-264
Authors: Kui Ma and Ya H. Tang

Radiochemotherapy for Non Small Cell Lung Cancer

Journal: Current Drug Therapy
Volume: 5,Issue: 3
Page: 180-191
Authors: Orazio Caffo and Viviana Murgia

Chemoradiotherapy in Locally Advanced, Unresectable Non-Small Cell Lung Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 4,Issue: 2
Page: 110-121
Authors: Lauren R. Mitchell, Jeffrey M. Albert and Bo Lu

Gene Expression Significance in Personalized Medicine of Non-small Cell Lung Cancer and Gene Expression Analyzing Platforms

Journal: Current Drug Metabolism
Volume: 12,Issue: 5
Page: 455-459
Authors: Li Zhang, Huiyi Yang and Jiasen Xu

The Role of Amitriptyline in the Management of Non-small Cell Lung Cancer

Journal: Current Cancer Therapy Reviews
Volume: 10,Issue: 3
Page: 284-288
Authors: John C. Ashton

Is there a Place for Bevacizumab in Patients with Extensive-Stage Small Cell Lung Cancer?

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 3
Page: 209-214
Authors: Giandomenico Roviello and Daniele Generali

Stage N2/IIIA Non Small Cell Lung Cancer: An Evidence-Based Review

Journal: Current Cancer Therapy Reviews
Volume: 3,Issue: 2
Page: 127-139
Authors: Christopher B. Komanapalli, Charles R. Thomas and Mithran S. Sukumar

Vinorelbine in the Treatment of Non-Small Cell Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 8
Page: 879-891
Authors: Cesare Gridelli and Rocco De. Vivo

The Role of Pemetrexed Combined with Gemcitabine for Non-Small-Cell Lung Cancer

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 61-66
Authors: Joanne Ngeow and Chee-Keong Toh

Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 85-94
Authors: Tianhong Li, Primo N. Lara Jr., Philip C. Mack, Roman Perez-Soler, David R. Gandara, Gert van Assche, Severine Vermeire and Paul Rutgeerts

Histotype in Non-Small Cell Lung Cancer Therapy and Staging: The Emerging Role of an Old and Underrated Factor

Journal: Current Respiratory Medicine Reviews
Volume: 3,Issue: 1
Page: 69-77
Authors: Giulio Rossi, Alessandro Marchioni, Giuliana Sartori, Lucia Longo, Silvia Piccinini and Alberto Cavazza

Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: A Review of Recent Clinical Trials

Journal: Reviews on Recent Clinical Trials
Volume: 2,Issue: 2
Page: 117-120
Authors: Carrie B. Lee and Mark A. Socinski

Targeted Therapies for Advanced Non-Small Cell Lung Cancer

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 15,Issue: 8
Page: 641-655
Authors: Ioannis Starakis, Achilleas Nikolakopoulos and Elias E. Mazokopakis

Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 5
Page: 646-650
Authors: Antonio Passaro, Daniele Alesini, Alessia Pochesci and Enrico Cortesi

Angiogenesis and Angiogenic Inhibitors in Non Small Cell Lung Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 3,Issue: 2
Page: 66-72
Authors: Nawfel Mellas, Zineb Benbrahim and Abdul Rahman Jazieh

Role of microRNA in Regulating Cell Signaling Pathways, Cell Cycle, and Apoptosis in Non-Small Cell Lung Cancer

Journal: Current Molecular Medicine
Volume: 16,Issue: 5
Page: 474-486
Authors: D.K. Singh, S. Bose and S. Kumar

Clinical Approaches to Immunotherapy in Non-Small Cell Lung Cancer: Current and Future Perspectives

Journal: Current Molecular Pharmacology
Volume: 9,Issue: 3
Page: 183-195
Authors: Shawn J. Rice, Bruce Miller, Matthias Wagman, Daniel S. Jamorabo, Xin Liu and Chandra P. Belani

Chemotherapy of Non-small Cell Lung Cancer in Elderly Patients

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 16
Page: 1487-1495
Authors: C. Gridelli, P. Maione, G. Colantuoni and A. Rossi

Hypofractionated Radiotherapy in Non Small Cell Lung Cancer: A Review of the Current Literature

Journal: Reviews on Recent Clinical Trials
Volume: 5,Issue: 2
Page: 103-111
Authors: Beli I., Koukourakis G., Platoni K., Tolia M., Kelekis N., Kouvaris J., Syrigos C., Mystakidou K., Varveris C. and Kouloulias V.

Targeted Therapies for Non-Small Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 27
Page: 2810-2831
Authors: G. S. Papaetis, C. Roussos and K. N. Syrigos

Selective Cyclooxygenase-2 Inhibitors and Non-small Cell Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 21
Page: 1851-1858
Authors: C. Gridelli, P. Maione, G. Airoma and A. Rossi

Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 8
Page: 893-898
Authors: Enriqueta Felip and Rafael Rosell

Small Molecule Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Non Small Cell Lung Cancer Treatment

Journal: Current Cancer Therapy Reviews
Volume: 3,Issue: 4
Page: 226-235
Authors: Clorinda Schettino, Maria Anna Bareschino, Paolo Maione, Antonio Rossi, Fortunato Ciardiello and Cesare Gridelli

Targeting Blood Vessels for the Treatment of Non-Small Cell Lung Cancer

Journal: Current Cancer Drug Targets
Volume: 8,Issue: 5
Page: 392-403
Authors: Ethan Amir, Sarah Hughes, Fiona Blackhall, Nick Thatcher, Gyula Ostoros, Jozsef Timar, Jozsef Tovari, Gabor Kovacs and Balazs Dome

Emerging Role of Stereotactic Radiotherapy (SRT) in the Treatment of Early Stage Non-Small Cell Lung Cancer

Journal: Current Cancer Therapy Reviews
Volume: 5,Issue: 4
Page: 281-287
Authors: Joshua D. Lawson, Ajay Sandhu, Steve Jiang and Arno J. Mundt

The Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 2-11
Authors: Krzysztof Konopa and Jacek Jassem

Role of Pemetrexed and Platinums Combination in Patients with Non- Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 29-36
Authors: Manyin Chen, Wenlong Shao, Jianxing He and Daoyuan Wang

The Role of Pemetrexed in Advanced Non Small-Cell Lung Cancer: Special Focus on Pharmacology and Mechanism of Action

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 37-47
Authors: M. Joerger, A. Omlin, T. Cerny and M. Fruh

Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 3
Page: 236-249
Authors: Mangeng Cheng and Gregory R. Ott

The Emerging Role of Histology in the Choice of First-Line Treatment of Advanced Non-Small Cell Lung Cancer: Implication in the Clinical Decision-Making

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 11
Page: 1030-1038
Authors: A. Rossi, P. Maione, M. A. Bareschino, C. Schettino, P. C. Sacco, M. L. Ferrara, V. Castaldo and C. Gridelli

Topotecan in Second-Line Treatment of Small-Cell Lung Cancer – How it Works in Our Daily Clinical Practice?

Journal: Current Drug Safety
Volume: 5,Issue: 2
Page: 114-117
Authors: Ana Luisa Lourenco Moreira Faria, Emilio Macias Bravo, Marta Alexandra Silva Soares Rocha, Isabel Maria Azevedo Rocha, Ana Luisa Pequeno Coelho and Antonio Manuel Ferreira Araujo

Paclitaxel Efficacy is Increased by Parthenolide via Nuclear Factor- KappaB Pathways in In Vitro and In Vivo Human Non – Small Cell Lung Cancer Models

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 7
Page: 705-715
Authors: Z. W. Gao, D. L. Zhang and C. B. Guo

Current Status and Future Directions of Multimodality Therapy for Non- Small Cell Lung Cancer of the Superior Sulcus

Journal: Current Cancer Therapy Reviews
Volume: 7,Issue: 1
Page: 2-9
Authors: Rachel E. Sanborn and Charles R. Thomas

Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non – small Cell Lung Cancer

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 2
Page: 107-123
Authors: S. A. Kono, L. E. Heasley, R. C. Doebele and D. R. Camidge

Role of EGFR Inhibitors in the Treatment of Central Nervous System Metastases from Non-Small Cell Lung Cancer

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 3
Page: 237-246
Authors: G. L. Ceresoli

Role of Tyrosine Kinase Inhibitor Molecules in Non Small Cell Lung Cancer:From Benchside to Bedside

Journal: Current Respiratory Medicine Reviews
Volume: 3,Issue: 2
Page: 159-167
Authors: Alessia Catassi, Alfredo Cesario, Pierluigi Granone and Patrizia Russo

The Role of Cetuximab and Other Epidermal Growth Factor Receptor Monoclonal Antibodies in the Treatment of Advanced Non-Small Cell Lung Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 3,Issue: 3
Page: 217-227
Authors: Antonio Rossi, Emilio Bria, Paolo Maione, Giovanni Palazzolo, Marzia Falanga and Cesare Gridelli

Second Line Treatments in Advanced Platinum-Resistant Non Small Cell Lung Cancer. A Critical Review of Literature

Journal: Reviews on Recent Clinical Trials
Volume: 4,Issue: 1
Page: 27-33
Authors: Davide Tassinari, Federica Carloni, Carlotta Santelmo, Emiliano Tamburini, Luigi Lazzari Agli, Paola Tombesi and Sergio Sartori

EGFR Mutation Testing in Non-Small Cell Lung Cancer

Journal: Current Respiratory Medicine Reviews
Volume: 6,Issue: 4
Page: 310-321
Authors: Krishna B. Sriram, Santiyagu M. Savarimuthu Francis, Maxine E. Tan, Rayleen V. Bowman, Ian A. Yang and Kwun M. Fong

Doxorubicin Sensitizes the Non-Small Cell Lung Cancer Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated (TRAIL) Apoptosis In Vitro but not In Vivo

Journal: Letters in Drug Design & Discovery
Volume: 8,Issue: 9
Page: 861-867
Authors: Li Fan, Liangran Guo, Jinfeng Ren, Yulong Ren, Zhiqing Pang and Xinguo Jiang

Insights into Angiogenesis in Non-Small Cell Lung Cancer: Molecular Mechanisms, Polymorphic Genes, and Targeted Therapies

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 7,Issue: 1
Page: 118-131
Authors: Ramon Andrade de Mello, Bruno M. Costa, Rui M. Reis and Venceslau Hespanhol

Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer: Update

Journal: Medicinal Chemistry Reviews - Online (Discontinued)
Volume: 1,Issue: 3
Page: 253-256
Authors: D. A. Arenberg

Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 2,Issue: 3
Page: 403-417
Authors: E.S. White, R.M. Strieter and D.A. Arenberg

Differential Serum Level of Specific Haptoglobin Isoforms in Small Cell Lung Cancer

Journal: Current Proteomics
Volume: 7,Issue: 1
Page: 49-56
Authors: Ankur Shah, Harpreet Singh, Vibhu Sachdev, James Lee, Sohiya Yotsukura, Ravi Salgia and Ajit Bharti

Bone Metastases and Non-Small Cell Lung Cancer: From Bisphosfonates to Targeted Therapy

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 32
Page: 5524-5535
Authors: A. Rossi, C. Gridelli, S. Ricciardi and F. de Marinis

Anti-Angiogenic Drugs and Biomarkers in Non-Small-Cell Lung Cancer: 'A Hard Days Night'

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 24
Page: 3958-3972
Authors: Sara Pilotto, Maria Bonomi, Francesco Massari, Michele Milella, Ludovica Ciuffreda, Matteo Brunelli, Matteo Fassan, Marco Chilosi, Aldo Scarpa, Giampaolo Tortora and Emilio Bria

Approaching the Increasing Complexity of Non-small Cell Lung Cancer Taxonomy

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 24
Page: 3973-3981
Authors: Marcello Maugeri-Sacca, Monica Bartucci, Alfredo Pagliuca, Michele Patrizii, Michele Signore and Ruggero De Maria

Clinical Pharmacology of EGFR/Met Inhibitors in Non-Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 15,Issue: 14
Page: 1263-1272
Authors: Shigehiro Yagishita and Akinobu Hamada

Epidermal Growth Factor Receptor Targeting in Non-Small Cell Lung Cancer: Revisiting Different Strategies Against the Same Target

Journal: Current Drug Targets
Volume: 15,Issue: 14
Page: 1273-1283
Authors: Eduardo Castanon, Patricia Martin, Christian Rolfo, Juan P. Fusco, Lucia Ceniceros, Jairo Legaspi, Marta Santisteban and Ignacio Gil-Bazo

MicroRNAs and Targeted Therapies in Non-small Cell Lung Cancer: Minireview

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 6
Page: 694-700
Authors: Carmelo Tibaldi, Armida D’Incecco and Alessandro Lagana

Anaplastic Lymphoma Kinase Inhibitors in Non-Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 17,Issue: 6
Page: 739-745
Authors: David M. Straughan, Sa d C. Azoury and Vivek Shukla

Paeonol Inhibits Migration, Invasion and Bone Adhesion of Small Cell Lung Cancer Cells

Journal: Current Signal Transduction Therapy
Volume: 10,Issue: 2
Page: 126-130
Authors: Yong Tian, Cong Chen, Yu Zhang, Zhen Zhang and Haiyan Xie

New Antiangiogenetic Therapy Beyond Bevacizumab in the Treatment of Advanced Non Small Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 32
Page: 4763-4772
Authors: Paola Claudia Sacco, Paolo Maione, Antonio Rossi, Assunta Sgambato, Francesca Casaluce, Giovanni Palazzolo and Cesare Gridelli

Role of EGFR Monoclonal Antibodies in the Management of Non–small Cell Lung Cancer

Journal: Current Cancer Drug Targets
Volume: 15,Issue: 9
Page: 792-802
Authors: Masayuki Takeda and Kazuhiko Nakagawa

Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non- Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management

Journal: Current Drug Safety
Volume: 11,Issue: 1
Page: 62-68
Authors: Assunta Sgambato, Francesca Casaluce, Paola C. Sacco, Giovanni Palazzolo, Paolo Maione, Antonio Rossi, Fortunato Ciardiello and Cesare Gridelli

Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 11,Issue: 4
Page: 297-305
Authors: Anshu Giri, Simrit S. Walia and Ajeet Gajra

Resistance to Crizotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) with ALK Rearrangement: Mechanisms, Treatment Strategies and New Targeted Therapies

Journal: Current Clinical Pharmacology
Volume: 11,Issue: 2
Page: 77-87
Authors: Francesca Casaluce, Assunta Sgambato, Paola Claudia Sacco, Giovanni Palazzolo, Paolo Maione, Antonio Rossi, Fortunato Ciardiello and Cesare Gridelli

Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 9
Page: 1142-1154
Authors: Federica Biello, Giovanni Burrafato, Erika Rijavec, Carlo Genova, Giulia Barletta, Anna Truini, Simona Coco, Maria Giovanna Dal Bello, Angela Alama, Francesco Boccardo and Francesco Grossi

Recent Development in the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Non-small Cell Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 6
Page: 590-613
Authors: Jingru Liu and Shutao Ma

The Combination of New Immunotherapy and Radiotherapy: A N ew Potential Treatment for Locally Advanced Non-Small Cell Lung Cancer

Journal: Current Clinical Pharmacology
Volume: 12,Issue: 1
Page: 4-10
Authors: Paola C. Sacco, Paolo Maione, Cesare Guida and Cesare Gridelli

Does Immunohistochemistry Represent a Robust Alternative Technique in Determining Drugable Predictive Gene Alterations in Non-Small Cell Lung Cancer?

Journal: Current Drug Targets
Volume: 18,Issue: 1
Page: 13-26
Authors: Giulio Rossi, Moira Ragazzi, Ione Tamagnini, Maria C. Mengoli, Giada Vincenzi, Fausto Barbieri, Silvia Piccioli, Alessandra Bisagni, Tiziana Vavala, Luisella Righi, Silvia Novello, Francesco Gelsomino and Marcello Tiseo

Recent Clinical Trials in Non-Small Cell Lung Cancer

Journal: Current Cancer Therapy Reviews
Volume: 2,Issue: 1
Page: 81-99
Authors: Suresh Ramalingam and Chandra P. Belani

Small RNAs and Non-Small Cell Lung Cancer

Journal: Current Molecular Medicine
Volume: 6,Issue: 3
Page: 339-349
Authors: Alex W. Tong

Epidermal Growth Factor Receptor (EGFR) Targeted Therapies in Non- Small Cell Lung Cancer (NSCLC)

Journal: Reviews on Recent Clinical Trials
Volume: 1,Issue: 1
Page: 1-13
Authors: Giulio Metro, Giovanna Finocchiaro, Luca Toschi, Stefania Bartolini, Elisabetta Magrini, Alessandra Cancellieri, Rocco Trisolini, Luciano Castaldini, Giovanni Tallini, Lucio Crino and Federico Cappuzzo

The Potential Role of Pharmacogenomic and Genomic in the Adjuvant Treatment of Early Stage Non Small Cell Lung Cancer

Journal: Current Genomics
Volume: 9,Issue: 4
Page: 252-262
Authors: Clorinda Schettino, Maria A. Bareschino, Paolo Maione, Antonio Rossi, Fortunato Ciardiello and Cesare Gridelli

FHIT and p53 Status and Response to Platinum-Based Treatment in Advanced Non-Small Cell Lung Cancer

Journal: Current Cancer Drug Targets
Volume: 8,Issue: 5
Page: 342-348
Authors: D. L. Cortinovis, F. Andriani, A. Livio, A. Fabbri, F. Perrone, B. Marcomini, S. Pilotti, L. Mariani, P. Bidoli, E. Bajetta, L. Roz and G. Sozzi

Positron Emission Tomography (PET) in the Evaluation of Response to Therapy in Non-Small Cell Lung Cancer

Journal: Current Cancer Therapy Reviews
Volume: 5,Issue: 1
Page: 20-27
Authors: Roberto C. Delgado-Bolton and Jose Luis Carreras Delgado

Angiogenesis Inhibitors and Vascular Disrupting Agents in Non-Small Cell Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 30
Page: 3919-3930
Authors: A. Rossi, P. Maione, M. L. Ferrara, P. C. Sacco, C. Schettino, M. A. Bareschino and C. Gridelli

The Role of Chemotherapy and Radiation in the Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 67-73
Authors: Timothy D. Wagner and Gary Y. Yang

Predictive Biomarkers to Tyrosine Kinase Inhibitors for the Epidermal Growth Factor Receptor in Non-Small-Cell Lung Cancer

Journal: Current Drug Targets
Volume: 11,Issue: 7
Page: 851-864
Authors: A. De Luca and N. Normanno

Vascular Endothelial Growth Factor Receptor as Target for Advanced Non-Small Cell Lung Cancer Therapy

Journal: Current Drug Targets
Volume: 11,Issue: 7
Page: 865-874
Authors: Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Rita Ambrosio, Marzia Falanga and Cesare Gridelli

Mechanisms of Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-Small-Cell Lung Cancer: Clinical and Molecular Considerations

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 11
Page: 1613-1628
Authors: A. Pallis, E. Briasoulis, H. Linardou, C. Papadimitriou, D. Bafaloukos, P. Kosmidis and S. Murray

Bevacizumab in Non Small Cell Lung Cancer: Development, Current Status and Issues

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 7
Page: 961-971
Authors: C. Sandomenico, R. Costanzo, G. Carillio, M. C. Piccirillo, A. Montanino, M. Di Maio, G. Rocco, N. Normanno, F. Perrone and A. Morabito

Chemoresistance in Non-Small Cell Lung Cancer

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 5,Issue: 1
Page: 73-88
Authors: Pascal Seve and Charles Dumontet

Recent Developments of Targeted Therapies in the Treatment of Non-Small Cell Lung Cancer

Journal: Current Drug Discovery Technologies
Volume: 6,Issue: 2
Page: 91-102
Authors: Antonio Rossi, Paolo Maione, Giuseppe Colantuoni, Carmine Ferrara, Emanuela Rossi, Ciro Guerriero, Dario Nicolella, Marzia Falanga, Giovanni Palazzolo and Cesare Gridelli

Pharmacokinetic Study of Weekly (Days 1-5) Low-dose S-1 in Patients with Non-Small-Cell Lung Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 7,Issue: 2
Page: 167-172
Authors: Tsuyoshi Shoji, Makoto Sonobe, Hiroaki Sakai, Takuji Fujinaga, Toshihiko Sato, Fengshi Chen, Ryo Miyahara, Toru Bando, Hiromi Wada and Hiroshi Date

Detection of EGFR Somatic Mutations in Non-Small Cell Lung Cancer (NSCLC) Using a Novel Mutant-Enriched Liquidchip (MEL) Technology

Journal: Current Drug Metabolism
Volume: 13,Issue: 7
Page: 1007-1011
Authors: Li Zhang, Huiyi Yang, Yanwei Zhao, Wenchao Liu, Shiyang Wu, Jiaying He, Xiaodi Luo, Zeyao Zhu, Jiasen Xu, Qinghua Zhou and Lifen Ren-Heidenreich

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 5
Page: 818-832
Authors: Elena Galvani, Roberta Alfieri, Elisa Giovannetti, Andrea Cavazzoni, Silvia La Monica, Maricla Galetti, Claudia Fumarola, Mara Bonelli, Marco Mor, Marcello Tiseo, Godefridus J. Peters, Pier Giorgio Petronini and Andrea Ardizzoni

Detection and Therapeutic Implications of c-Met Mutations in Small Cell Lung Cancer and Neuroendocrine Tumors

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 5
Page: 833-840
Authors: J. Voortman, T. Harada, R.P. Chang, J.K. Killian, M. Suuriniemi, W.I. Smith, P.S. Meltzer, M. Lucchi, Y. Wang and G. Giaccone


Integrated Therapeutic Approaches in the Treatment of Locally Advanced Non-small Cell Lung Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 6
Page: 844-851
Authors: Massimo Di Maio, Raffaele Costanzo, Pasqualina Giordano, Maria Carmela Piccirillo, Claudia Sandomenico, Agnese Montanino, Guido Carillio, Paolo Muto, David R. Jones, Gennaro Daniele, Francesco Perrone, Gaetano Rocco and Alessandro Morabito

Selumetinib in Advanced Non Small Cell Lung Cancer (NSCLC) Harbouring KRAS Mutation: Endless Clinical Challenge to KRAS-mutant NSCLC.

Journal: Reviews on Recent Clinical Trials
Volume: 8,Issue: 2
Page: 93-100
Authors: Paolo Maione, Assunta Sgambato, Antonio Rossi, Paola Claudia Sacco, Maria Anna Bareschino, Clorinda Schettino, Francesca Casaluce, Fortunato Ciardiello and Cesare Gridelli

Pharmacogenetics of Non-small Cell Lung Cancer (NSCLC): Time to "Work it Out"?

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 24
Page: 3863-3874
Authors: Elena Galvani, Francesca Toffalorio, Godefridus J. Peters, Tommaso De Pas and Elisa Giovannetti

Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer

Journal: Current Pharmaceutical Biotechnology
Volume: 15,Issue: 5
Page: 475-485
Authors: Christian Rolfo, Daniele Fanale, David S. Hong, Apostolia M. Tsimberidou, Sarina A. Piha-Paul, Patrick Pauwels, Jan P. Van Meerbeeck, Stefano Caruso, Viviana Bazan, Giuseppe Cicero, Antonio Russo and Elisa Giovannetti

Prognostic Markers in Small Cell Lung Cancer

Journal: Current Cancer Therapy Reviews
Volume: 10,Issue: 1
Page: 39-46
Authors: Myles Nickolich and Afshin Dowlati

Immune Checkpoint Inhibitors for Non-small-cell Lung Cancer: Does that Represent a ‘New Frontier’?

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 3
Page: 307-313
Authors: Sara Pilotto, Stefania Kinspergher, Umberto Peretti, Anna Calio, Luisa Carbognin, Roberto Ferrara, Matteo Brunelli, Marco Chilosi, Giampaolo Tortora and Emilio Bria

Next Generation Sequencing in Non-Small Cell Lung Cancer: New Avenues Toward the Personalized Medicine

Journal: Current Drug Targets
Volume: 16,Issue: 1
Page: 47-59
Authors: Simona Coco, Anna Truini, Irene Vanni, Maria Giovanna Dal Bello, Angela Alama, Erika Rijavec, Carlo Genova, Giulia Barletta, Claudio Sini, Giovanni Burrafato, Federica Biello, Francesco Boccardo and Francesco Grossi

A Computational Study of Three Frequent Mutations of EGFR and their Effects on Protein Dimer Formation and Non-Small Cell Lung Cancer Drug Resistance

Journal: Current Bioinformatics
Volume: 11,Issue: 3
Page: 382-391
Authors: Zhiyong Shen, Debby D. Wang, Lichun Ma, Hong Yan, Maria P. Wong and Victor H.F. Lee

Challenges and Strategies in Precision Medicine for Non-Small-Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 28
Page: 4374-4385
Authors: Joseph J. Sacco, Hussein Al-Akhrass and Cornelia M. Wilson

EGFR and EML4-ALK Updated Therapies in Non-Small Cell Lung Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 11,Issue: 4
Page: 393-400
Authors: Ramon Andrade de Mello, Davi J. J. Liu, Pedro N. Aguiar and Hakaru Tadokoro

The Role of the Antiangiogenetic Ramucirumab in the Treatment of Advanced Non Small Cell Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 1
Page: 3-13
Authors: Paolo Maione, Assunta Sgambato, Francesca Casaluce, Paola Claudia Sacco, Giuseppe Santabarbara, Antonio Rossi and Cesare Gridelli

Bonafide Targets of Deregulated microRNAs in Non-Small Cell Lung Cancer as Tool to Identify Novel Therapeutic Targets: A Review

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 1
Page: 55-72
Authors: Monica Cipollini, Stefano Landi and Federica Gemignani

Interaction of Treatment and Biomarker in Advanced Non-small Cell Lung Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 12,Issue: 1
Page: 51-58
Authors: Pingfu Fu, Nathan A. Pennell, Neelesh Sharma, Qizhi Yi and Afshin Dowlati

Targeted Therapies in Non-Small Cell Lung Cancer: Proven Concepts and Unfulfilled Promises.

Journal: Current Cancer Drug Targets
Volume: 6,Issue: 4
Page: 271-294
Authors: Jutta Auberger, Judith Loeffler-Ragg, Walter Wurzer and Wolfgang Hilbe

Docetaxel (Taxotere) in the Treatment of Non-Small Cell Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 8
Page: 869-877
Authors: Vassilis Georgoulias

Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 12-28
Authors: Elisa Giovannetti, Richard Honeywell, Axel R. Hanauske, Christina Tekle, Bart Kuenen, Jennifer Sigmond, Giuseppe Giaccone and Godefridus J. Peters

The Role of Pemetrexed in Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 58-60
Authors: Steven Tucker

Pemetrexed: Potential Role in the Adjuvant Chemotherapy of Non-Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 78-84
Authors: Mark Vincent

The Natural Tumor Suppressor Protein Maspin and Potential Application in Non Small Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 16
Page: 1877-1881
Authors: Fulvio Lonardo, Xiaohua Li, Alexander Kaplun, Ayman Soubani, Seema Sethi, Shirish Gadgeel and Shijie Sheng

Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and New Therapeutic Perspectives in Non Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 12,Issue: 6
Page: 922-933
Authors: Laura Bonanno, Antonio Jirillo and Adolfo Favaretto

The Hypomethylation Agent Bisdemethoxycurcumin Acts on the WIF-1 Promoter, Inhibits the Canonical Wnt Pathway and Induces Apoptosis in Human Non-Small-Cell Lung Cancer

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 9
Page: 1098-1110
Authors: Y.-L. Liu, H.-P. Yang, X.-D. Zhou, L. Gong, C.-L. Tang and H.-J. Wang

Pharmacogenomics of Non-Small Cell Lung Cancer

Journal: Current Pharmacogenomics
Volume: 5,Issue: 3
Page: 228-234
Authors: James Spicer, Andrew Futreal and Johann De Bono

Current Status of Clinical Trials for Small Cell Lung Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 3,Issue: 1
Page: 40-61
Authors: Alexandre Arcaro and Barbara Fischer

Prevention of VP-16 Resistance by a Disiloxane, SILA409: Effects of SILA409 on the Expression of GRP78 in NCI-H446 Human Small Cell Lung Cancer Cells

Journal: Letters in Drug Design & Discovery
Volume: 8,Issue: 8
Page: 691-697
Authors: Encheng Li, Jinhui Zhang, Jiarui Wang, Fei Gao, Zhonghai Yang, Qiang Meng, Qianqian Zhang, Na Li, Ming Huang, Gabriella Spengler, Joseph Molnar and Qi Wang

An Overview: Current Systemic Therapies for Advanced Non-Small Cell Lung Cancer

Journal: Current Respiratory Medicine Reviews
Volume: 7,Issue: 5
Page: 354-363
Authors: Michael Ong and Mark D. Vincent

Esophagitis, Treatment-Related Toxicity in Non-Small Cell Lung Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 7,Issue: 1
Page: 31-35
Authors: Voichita Bar-Ad, Nitin Ohri and Maria Werner-Wasik

Non-Small Cell Lung Cancer: From Cytotoxic Systemic Chemotherapy to Molecularly Targeted Therapy

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 4,Issue: 3
Page: 231-245
Authors: Alfredo Cesario, Sonya Trombino, Domenico Galetta, Stefano Margaritora, Carmelina Murolo, Lorenzo Dominioni, Andrea Imperatori, Luigi Festi, Pierluigi Granone and Patrizia Russo

Recent Patents for Predictive and Prognostic Biomarkers in Non-Small-Cell Lung Cancer

Journal: Recent Patents on Biomarkers
Volume: 1,Issue: 2
Page: 119-138
Authors: Vassiliki Saloura and Petros D. Grivas

The Role of EGFR Tyrosine Kinase Inhibitors in the First-Line Treatment of Advanced Non Small Cell Lung Cancer Patients Harboring EGFR Mutation

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 20
Page: 3337-3352
Authors: A. Sgambato, F. Casaluce, P. Maione, A. Rossi, E. Rossi, A. Napolitano, G. Palazzolo, M. A. Bareschino, C. Schettino, P. C. Sacco, F. Ciadiello and C. Gridelli

Molecular Mechanisms and Modulation of Key Pathways Underlying the Synergistic Interaction of Sorafenib with Erlotinib in Non-Small-Cell-Lung Cancer (NSCLC) Cells

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 5
Page: 927-939
Authors: E. Giovannetti, M. Labots, H. Dekker, E. Galvani, J.S.W. Lind, R. Sciarrillo, R. Honeywell, E.F. Smit, H.M. Verheul and G.J. Peters

MicroRNAs in Non-small Cell Lung Cancer: Current Status and Future Therapeutic Promises

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 24
Page: 3982-3990
Authors: D. Cortinovis, V. Monica, F Pietrantonio, G.L. Ceresoli, C.M. La Spina and L. Wannesson

Across the Universe of K-Ras Mutations in Non-Small-Cell-Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 24
Page: 3933-3943
Authors: Sheila Piva, Monica Ganzinelli, Marina Chiara Garassino, Elisa Caiola, Gabriella Farina, Massimo Broggini and Mirko Marabese

PARP Inhibitors: An Interesting Pathway also for Non-Small Cell Lung Cancer?

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 24
Page: 3875-3882
Authors: Matteo Giaj Levra, Ken Andre Olaussen, Silvia Novello and Jean-Charles Soria

The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFRInhibitors: Did We Really Find the Target?

Journal: Current Drug Targets
Volume: 15,Issue: 14
Page: 1284-1292
Authors: Francesco Passiglia, Nele Van Der Steen, Luis Raez, Patrick Pauwels, Ignacio Gil-Bazo, Edgardo Santos, Daniele Santini, Giovanni Tesoriere, Antonio Russo, Giuseppe Bronte, Karen Zwaenepoel, Federico Cappuzzo and Christian Rolfo

Application of PET to the Diagnosis, Staging, and Treatment of Locally Advanced Non-small Cell Lung Cancer

Journal: Current Medical Imaging Reviews
Volume: 11,Issue: 2
Page: 91-98
Authors: Fei Li and Mark Landis

Metabolic Response Assessment in Non-Small Cell Lung Cancer Patients after Platinum-Based Therapy: A Preliminary Analysis

Journal: Current Medical Imaging Reviews
Volume: 11,Issue: 4
Page: 218-227
Authors: Alessandro Stefano, Nunziatina Porcino, Giuseppe Banna, Giorgio Russo, Vanessa Mocciaro, Giuseppe Anile, Stefania Gieri, Sebastiano Cosentino, Gabriella Mure, Sara Baldari, Maria Gabriella Sabini, Danile Sardina, Filippo Fraggetta, Salvatore Vitabile, Maria Carla Gilardi and Massimo Ippolito

Immunotherapy for Non-Small Cell Lung Cancer - Finally a Hint of Hope

Journal: Reviews on Recent Clinical Trials
Volume: 11,Issue: 2
Page: 87-92
Authors: Gonzalo Recondo, Gonzalo Recondo, Fernando Galanternik, Martín Greco, Máximo de la Vega, E. Diaz Cantón and Matías E. Valsecchi

Pharmacological Approaches in an Experimental Model of Non-Small Cell Lung Cancer: Effects on Tumor Biology

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 34
Page: 5300-5310
Authors: Mercè Mateu-Jimenez, Clara Fermoselle, Federico Rojo, Javier Mateu, Raúl Peña, Alejandro J. Urtreger, Miriam J. Diament, Elisa D. Bal de Kier Joffé, Lara Pijuan, Antonio García de Herreros and Esther Barreiro

Comparative Proteomics and Bioinformatics Analysis of Tissue from Non-Small Cell Lung Cancer Patients

Journal: Current Proteomics
Volume: 14,Issue: 1
Page: 58-77
Authors: Sevgi Gezici, Mehmet Ozaslan, Gurler Akpinar, Murat Kasap, Maruf Sanli and Levent Elbeyli

Lung Cancer Chemotherapy, New Treatment and Related Patents

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 9,Issue: 3
Page: 372-381
Authors: Attapon Cheepsattayakorn and Ruangrong Cheepsattayakorn

Lung Cancer Vaccines

Journal: Current Gene Therapy
Volume: 7,Issue: 6
Page: 469-484
Authors: Rob Eager, Lindsey Harle and John J. Nemunaitis

Apoptosis and Apoptosis-Based Therapy in Lung Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 9
Page: 952-957
Authors: Cheng-Xiong Xu, Hua Jin and Myung-Haing Cho

Genomic and Cellular Pathology of Lung Cancer

Journal: Current Respiratory Medicine Reviews
Volume: 7,Issue: 5
Page: 313-322
Authors: Sandy D. Der, Roya Navab, Kota Ishizawa and Ming-Sound Tsao

Combined Modality Treatment of Limited Stage Small Cell Carcinoma of the Lung

Journal: Reviews on Recent Clinical Trials
Volume: 3,Issue: 2
Page: 150-155
Authors: Don Yee, Brita Danielson and Wilson Roa

Tumor Markers in Patients with Benign and Malignant Pulmonary Diseases; Competitive Evaluation of ProGRP, NSE and Cyfra 21-1

Journal: Recent Patents on Biomarkers
Volume: 3,Issue: 2
Page: 145-152
Authors: Bijan B. Dilmaghani-Marand and Gerhard M. Oremek

Natural Compounds with Cell Growth Inhibitory Activity in Human Tumor Cell Lines

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 10
Page: 1582-1589
Authors: Cristiane M. Cazal, Kantima Choosang, Vanessa Gisele P. Severino, João B. Fernandes, Maria Fátima G. F. da Silva, Paulo C. Vieira, Maria S. J. Nascimento, Gabriela M. Almeida, M. Helena Vasconcelos, Pannee Pakkong and Madalena M. M. Pinto

Transbronchial Needle Aspiration (TBNA): Past Present and Future

Journal: Current Respiratory Medicine Reviews
Volume: 10,Issue: 3
Page: 176-181
Authors: C. Gilbert, R. Ortiz, Y. Ma, H.J. Lee, L. Yarmus and K. Wang

Etoposide: Discovery and Medicinal Chemistry

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 18
Page: 2443-2466
Authors: Philippe Meresse, Elsa Dechaux, Claude Monneret and Emmanuel Bertounesque

Neuropeptides as Autocrine Growth Factors in Cancer Cells

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 6
Page: 495-509
Authors: Terry W. Moody, Daniel Chan, Jan Fahrenkrug and Robert T. Jensen

Targeted Therapies in Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 2
Page: 188-206
Authors: Robert Pirker and Martin Filipits

In Vitro Synergistic Interaction between DTA0100 and Radiation in Human Cancer Cell Lines

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 8
Page: 988-993
Authors: Elisa Bordon, Leticia G. Leon, Carla Rios-Luci, Pedro C. Lara and Jose M. Padron

Irreversible EGFR Inhibitors in the Treatment of Advanced NSCLC

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 24
Page: 3894-3900
Authors: Paolo Maione, Antonio Rossi, Marianna Bareschino, Paola Claudia Sacco, Clorinda Schettino, Francesca Casaluce, Assunta Sgambato and Cesare Gridelli

Segmentation and Classification of Lung Cancer: A Review

Journal: Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 16,Issue: 2
Page: 82-99
Authors: Javeria Amin, Muhammad Sharif and Mussarat Yasmin

Evaluation of Effect of Triterpenes and Limonoids on Cell Growth, Cell Cycle and Apoptosis in Human Tumor Cell Lines

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 10
Page: 769-776
Authors: Cristiane M. Cazal, Kantima Choosang, Vanessa Gisele P. Severino, Marcio S. Soares, Andre Lucio F. Sarria, Joao B. Fernandes, Maria Fatima G.F. Silva, Paulo Cezar Vieira, Pannee Pakkong, Gabriela M. Almeida, M. Helena Vasconcelos, Maria S.J. Nascimento and Madalena M.M. Pinto

A Review of the Treatment Strategies for Small Cell Lung Carcinoma Patients with a Poor Performance Status

Journal: Current Respiratory Medicine Reviews
Volume: 2,Issue: 1
Page: 59-66
Authors: S. Rehman, S. Baka, S. Lau, F. Blackhall, P. Lorigan and N. Thatcher

Heparin Affin Regulatory Peptide: A New Target for Tumour Therapy?

Journal: Current Cancer Drug Targets
Volume: 4,Issue: 6
Page: 471-482
Authors: E. Papadimitriou, A. Polykratis, M. Hatziapostolou, A. Parthymou, C. Polytarchou and C. Mikelis

Lung Cancer: Are we up to the Challenge?

Journal: Current Genomics
Volume: 11,Issue: 7
Page: 513-518
Authors: Luca Esposito, Daniele Conti, Ramyasri Ailavajhala, Nansie Khalil and Antonio Giordano

Metallothioneins and Cancer

Journal: Current Protein & Peptide Science
Volume: 10,Issue: 4
Page: 360-375
Authors: Tomas Eckschlager, Vojtech Adam, Jan Hrabeta, Katarina Figova and Rene Kizek

HGF-MET in Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer

Journal: Current Signal Transduction Therapy
Volume: 6,Issue: 2
Page: 228-233
Authors: Seiji Yano, Wei Wang, Qi Li, Tadaaki Yamada, Shinji Takeuchi, Kunio Matsumoto, Yasuhiko Nishioka and Saburo Sone

Recent Progress in Therapeutic and Diagnostic Applications of Lanthanides

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11,Issue: 8
Page: 678-694
Authors: J. Zhang, Y. Li, X. Hao, Q. Zhang, K. Yang, L. Li, L. Ma, S. Wang and X. Li

Radiation Therapy in the Management of Lung Cancer

Journal: Current Respiratory Medicine Reviews
Volume: 7,Issue: 5
Page: 323-339
Authors: Tarek Hijal, Jonathan Wan and Luis Souhami

Synthesis, Topoisomerase I Inhibitory and Cytotoxic Activities of Chromone Derivatives

Journal: Medicinal Chemistry
Volume: 9,Issue: 3
Page: 329-339
Authors: Chirattikan Maicheen, Jiraphun Jittikoon, Opa Vajragupta and Jiraporn Ungwitayatorn

MET and ALK as Targets for the Treatment of NSCLC

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 24
Page: 3914-3932
Authors: Capelletti M, Gelsomino F. and Tiseo M.

Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 9,Issue: 3
Page: 382-393
Authors: Suresh Kumar and Ritesh Agrawal

Recent Advance in Drug Development of Squamous Cell Carcinoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 7
Page: 816-827
Authors: Jun Lei, Bing Fu, Hang Yin, Guanxiu Tang, Shujuan Zhu, Chunli Yan and Quanyong He

Design, Synthesis and Biological Evaluation of Quinoxalin-2(1H)-one Derivatives as EGFR Tyrosine Kinase Inhibitors

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 2
Page: 267-273
Authors: Xuemei Qin, Xiao Han, Liming Hu, Zhipeng Li, Zhufeng Geng, Zhanyang Wang, Chengchu Zeng and Xiangqian Xiao

Current Molecularly Targeting Therapies in NSCLC and Melanoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 7
Page: 856-868
Authors: Supriya Rajanna, Ichwaku Rastogi, Luke Wojdyla, Hiroko Furo, Agnes Kulesza, Leo Lin, Bonnie Sheu, Mark rakes, Marko Ivanovich and Neelu Puri

Pivotal Role of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 in Inflammatory Pulmonary Diseases

Journal: Current Protein & Peptide Science
Volume: 17,Issue: 4
Page: 332-342
Authors: Feng Qian, Jing Deng, Gang Wang, Richard D. Ye and John W. Christman

Growth Inhibition of Human Non-Small Lung Cancer Cells H460 By Green Tea and Ginger Polyphenols

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 4
Page: 383-390
Authors: Mohamed Hessien, Saad El-Gendy, Thoria Donia and Morsy Abou Sikkena

Neuroendocrine Tumors of the Lung: Hystological Classification, Diagnosis, Traditional and New Therapeutic Approaches

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 9
Page: 1107-1116
Authors: A. Cueto, F. Burigana, A. Nicolini and F. Lugnani

Feature Classification and Analysis of Lung Cancer Related Genes through Gene Ontology and KEGG Pathways

Journal: Current Bioinformatics
Volume: 11,Issue: 1
Page: 40-50
Authors: You Zhou, Biqing Li, Yuchao Zhang, Lei Chen and Xiangyin Kong

Neuronal Acetylcholine Nicotinic Receptors as New Targets for Lung Cancer Treatment

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 14
Page: 2160-2169
Authors: Vanessa Mucchietto, Arianna Crespi, Francesca Fasoli, Francesco Clementi and Cecilia Gotti

Arsenic Trioxide Exerts Anti-lung Cancer Activity by Inhibiting Angiogenesis

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 6
Page: 557-566
Authors: Meng-Hang Yang, Yuan-Sheng Zang, Hai Huang, Kun Chen, Bing Li, Guang-Yuan Sun and Xue-Wei Zhao

Interferon Therapy in Lung Cancer: Current Perspectives

Journal: Current Cancer Therapy Reviews
Volume: 12,Issue: 4
Page: 237-245
Authors: Debosree Ghosh and Pratap Parida

The Potential and Rationale for COX-2 Inhibitors in Lung Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 6,Issue: 3
Page: 209-220
Authors: Kostyantyn Krysan, Karen L. Reckamp, Sherven Sharma and Steven M. Dubinett

Overview of Ribonucleotide Reductase Inhibitors: An Appealing Target in Anti-Tumour Therapy

Journal: Current Medicinal Chemistry
Volume: 12,Issue: 11
Page: 1283-1294
Authors: Nuno M.F.S.A. Cerqueira, Susana Pereira, Pedro A. Fernandes and Maria J. Ramos

High Throughput Screening for Protein Kinase Inhibitors

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 8,Issue: 2
Page: 181-195
Authors: Holger Wesche, Shou-Hua Xiao and Steve W. Young

Optimizing Anti-EGFR Strategies in Cancer Treatment

Journal: Current Cancer Therapy Reviews
Volume: 3,Issue: 4
Page: 267-275
Authors: Luca Toschi, Giovanna Finocchiaro, Isabella Garassino, Fabio De Vincenzo, Elisabetta Campagnoli, Giovanni Luca Ceresoli, Raffaele Cavina, Paolo Andrea Zucali, Armando Santoro and Federico Cappuzzo

Methodological Issues of Clinical Research with EGFR Inhibitors

Journal: Current Cancer Therapy Reviews
Volume: 3,Issue: 4
Page: 292-302
Authors: Alessandro Morabito, Maria Carmela Piccirillo, Katia Monaco, Fabiano Falasconi, Nicola Normanno and Francesco Perrone

Receptor Tryosine Kinase Inhibitors as Potent Weapons in War Against Cancers

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 7
Page: 758-776
Authors: P. Sapra Sharma, R. Sharma and T. Tyagi

Fibrates in the Chemical Action of Daunorubicin

Journal: Current Cancer Drug Targets
Volume: 9,Issue: 3
Page: 366-369
Authors: Ganesaratnam K. Balendiran

Clinical Development of Inhibitors of the Insulin-like Growth Factor Receptor in Oncology

Journal: Current Drug Targets
Volume: 10,Issue: 10
Page: 923-936
Authors: Antonio Gualberto and Michael Pollak

Predictive Markers for Haematological Toxicity of Pemetrexed

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 48-57
Authors: S. C.H. Kao, V. H. Phan and S. J. Clarke

Lung Cancer Stem Cells as a Target for Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 2
Page: 164-171
Authors: Elieser Gorelik, Anna Lokshin and Vera Levina

Targeting CREB for Cancer Therapy: Friend or Foe

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 4
Page: 384-391
Authors: X. Xiao, B.X. Li, B. Mitton, A. Ikeda and K.M. Sakamoto

Monoclonal Antibodies in Solid Tumours

Journal: Current Clinical Pharmacology
Volume: 5,Issue: 3
Page: 160-165
Authors: Ben Markman and Josep Tabernero

INNO-206 (DOXO-EMCH), an Albumin-Binding Prodrug of Doxorubicin Under Development for Phase II Studies

Journal: Current Bioactive Compounds
Volume: 7,Issue: 1
Page: 33-38
Authors: F. Kratz

Targeted Therapies and other Agents as First-Line Maintenance and Beyond: Particular Benefit in Pulmonary Adenocarcinoma Patients

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 11
Page: 1640-1650
Authors: F. Petrelli, K. Borgonovo, M. Cabiddu, M. Ghilardi and S. Barni

Efficacy and Tolerability of Vinorelbine in the Cancer Therapy

Journal: Current Drug Safety
Volume: 6,Issue: 3
Page: 185-193
Authors: Giuseppina Galano, Mariella Caputo, Mario Felice Tecce and Anna Capasso

Cardiotonic Steroids-Mediated Targeting of the Na+/K+-ATPase to Combat Chemoresistant Cancers

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 5
Page: 627-646
Authors: T. Mijatovic, F. Dufrasne and R. Kiss

Bortezomib in the Treatment of Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1,Issue: 3
Page: 397-403
Authors: Aldo M. Roccaro, Angelo Vacca and Domenico Ribatti

Radiation-Induced Lung Injury Following Therapy for Thoracic Malignancy

Journal: Current Respiratory Medicine Reviews
Volume: 1,Issue: 3
Page: 317-323
Authors: Ross K. Morgan, Lisa A. Kachnic and Ross Summer

Clinico-Pathologic and Biologic Predictors of EGFR Inhibitors Activity and Efficacy in Lung and in Colorectal Cancer

Journal: Current Signal Transduction Therapy
Volume: 3,Issue: 3
Page: 234-243
Authors: Maria Anna Bareschino, Clorinda Schettino, Linda Alvino, Cesare Gridelli and Fortunato Ciardiello

Applications of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) in Pulmonary Disease

Journal: Current Respiratory Medicine Reviews
Volume: 6,Issue: 2
Page: 133-141
Authors: Andrew R.L. Medford

Synthesis of Xanthones and Benzophenones as Inhibitors of Tumor Cell Growth

Journal: Letters in Drug Design & Discovery
Volume: 7,Issue: 7
Page: 487-493
Authors: Elisangela Costa, Emilia Sousa, Nair Nazareth, Maria S.J. Nascimento and Madalena M.M. Pinto

Recent Advances in Small Molecule Inhibitors of VEGFR and EGFR Signaling Pathways

Journal: Current Topics in Medicinal Chemistry
Volume: 11,Issue: 12
Page: 1571-1590
Authors: Haizhen Zhong and J. Phillip Bowen

Second Generation Taxanes: from the Natural Framework to the Challenge of Drug Resistance

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 3,Issue: 2
Page: 133-138
Authors: Cristiano Ferlini, Iwao Ojima, Mariagrazia Distefano, Daniela Gallo, Antonella Riva, Paolo Morazzoni, Ezio Bombardelli, Salvatore Mancuso and Giovanni Scambia

Recent Developments of Small Molecule EGFR Inhibitors Based on the Quinazoline Core Scaffolds

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 4
Page: 391-406
Authors: Yu-Jing Liu, Cheng-Mei Zhang and Zhao-Peng Liu

Is α7-nAChR a Possible Target for Lung Cancer and Malignant Pleural Mesothelioma Treatment?

Journal: Current Drug Targets
Volume: 13,Issue: 5
Page: 688-694
Authors: Alfredo Cesario, Patrizia Russo, Candida Nastrucci and Pierluigi Granone

Application of Monoclonal Antibodies as Cancer Therapy in Solid Tumors

Journal: Current Clinical Pharmacology
Volume: 7,Issue: 2
Page: 137-145
Authors: Rodrigo Dienstmann, Ben Markman and Josep Tabernero

Paraneoplastic Neurological Syndromes - Diagnosis and Management

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 29
Page: 4518-4525
Authors: Franz Blaes

DYRK1A Kinase Inhibitors with Emphasis on Cancer

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 12,Issue: 13
Page: 1315-1329
Authors: A. Ionescu, F. Dufrasne, M. Gelbcke, I. Jabin, R. Kiss and D. Lamoral-Theys

Aflibercept: A Novel VEGF Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Tumors

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13,Issue: 4
Page: 530-540
Authors: Tina Sharma, Richa Dhingra, Sukhminder Singh, Shivani Sharma, Prince Tomar, Manav Malhotra and T. R. Bhardwaj

Design, Synthesis and Molecular Modeling Studies of Some Heterocyclic Compounds Derived from the Suzuki-coupling of 6-bromo-1,3,4-oxadiazine Together with their Antitumor and Anti-leishmanial Evaluations

Journal: Current Organic Chemistry
Volume: 17,Issue: 17
Page: 1910-1918
Authors: Rafat M. Mohareb, Sherif M. Sherif and Adel Abou Elkair

Metabolite Characterization of Anti-cancer Agent Gefitinib in Human Hepatocytes

Journal: Drug Metabolism Letters
Volume: 7,Issue: 2
Page: 126-136
Authors: Prashant Surve, Selvan Ravindran, Arghya Acharjee, Himanshu Rastogi, Sudipta Basu and Pradnya Honrao

Gold Salts Therapy in Respiratory Diseases

Journal: Current Respiratory Medicine Reviews
Volume: 9,Issue: 5
Page: 328-333
Authors: Ori-Michael J. Benhamou, Maly N. Oron, Maor Waldman and Or Kalchiem-Dekel

Non-Small Cell Lung Carcinoma: An Overview on Targeted Therapy

Journal: Current Drug Targets
Volume: 16,Issue: 13
Page: 1448-1463
Authors: Ana Vanessa Nascimento, Hassan Bousbaa, Domingos Ferreira and Bruno Sarmento

A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 1
Page: 37-47
Authors: Subhajit Roy, Bawneet K. Narang, Shiva K. Rastogi and Ravindra K. Rawal

ATP Citrate Lyase (ACLY): A Promising Target for Cancer Prevention and Treatment

Journal: Current Drug Targets
Volume: 16,Issue: 2
Page: 156-163
Authors: Amrita Devi Khwairakpam, Mayengbam Singh Shyamananda, Bethsebie Lalduhsaki Sailo, Sivakumar Raju Rathnakaram, Ganesan Padmavathi, Jibon Kotoky and Ajaikumar B. Kunnumakkara

Development of Hedgehog Pathway Inhibitors (HPI) in Treatment of Cancer

Journal: Current Chemical Biology
Volume: 8,Issue: 3
Page: 132-148
Authors: Dipankar Pramanik

Analysis of the relationship between PM2.5 and lung cancer based on protein-protein interactions

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 19,Issue: 2
Page: 100-108
Authors: Yang Shu, Liucun Zhu, Fei Yuan, Xiangyin Kong, Tao Huang and Yu-Dong Cai

Review on EGFR Inhibitors: Critical Updates

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 16,Issue: 14
Page: 1134-1166
Authors: Davinder Singh, Bhupinder Kumar Attri, Rupinder Kaur Gill and Jitender Bariwal

Role of Colloidal Drug Delivery Carriers in Taxane-mediated Chemotherapy: A Review

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 33
Page: 5127-5143
Authors: Pramod Kumar, Kaisar Raza, Lokesh Kaushik, Ruchi Malik, Shweta Arora and Om Prakash Katare

Pharmacokinetics of Gefitinib: Roles of Drug Metabolizing Enzymes and Transporters

Journal: Current Drug Delivery
Volume: 14,Issue: 2
Page: 282-288
Authors: Can Zhao, Shu-Yan Han and Ping-Ping Li

3D-QSAR and Docking Studies on 2-acyliminobenzimidazoles Derivatives as Potent ALK Inhibitors

Journal: Letters in Drug Design & Discovery
Volume: 12,Issue: 3
Page: 219-233
Authors:

Genetics of Preneoplasia: Lessons from Lung Cancer

Journal: Current Molecular Medicine
Volume: 7,Issue: 1
Page: 3-14
Authors: Ignacio I. Wistuba

Design of New Oxazaphosphorine Anticancer Drugs

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 9
Page: 963-978
Authors: Jun Liang, Min Huang, Wei Duan, Xue-Qing Yu and Shufeng Zhou

Genetically Modified Dendritic Cells for Cancer Immunotherapy

Journal: Current Gene Therapy
Volume: 5,Issue: 6
Page: 619-628
Authors: Antoni Ribas

Bombesin-like Peptides: Candidates as Diagnostic and Therapeutic Tools

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 12
Page: 1013-1022
Authors: B. C. Yegen

Lessons Learned from the Irinotecan Metabolic Pathway

Journal: Current Medicinal Chemistry
Volume: 10,Issue: 1
Page: 41-49
Authors: M. K. Ma and H. L. McLeod

Cell Cycle Molecular Targets in Novel Anticancer Drug Discovery

Journal: Current Pharmaceutical Design
Volume: 6,Issue: 4
Page: 379-392
Authors: John K. Buolamwini

The History, Mechanism and Clinical Use of Oral 5-Fluorouracil Derivative Chemotherapeutic Agents

Journal: Current Pharmaceutical Biotechnology
Volume: 1,Issue: 2
Page: 137-164
Authors: Fumihiro Tanaka, Tatsuo Fukuse, Hiromi Wada and Masakazu Fukushima

ANTI-ADHESION Evolves To a Promising Therapeutic Concept in Oncology

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 10
Page: 978-990
Authors: R. Schmidmaier and P. Baumann

The Epidermal Growth Factor Receptor as a Therapeutic Target in Glioblastoma Multiforme and other Malignant Neoplasms

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 6
Page: 703-715
Authors: S. Loew, U. Schmidt, A. Unterberg and M.-E. Halatsch

Mechanisms of Cytotoxicity of Anticancer Titanocenes

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 4
Page: 302-311
Authors: Ulrike Olszewski and Gerhard Hamilton

Metabolic Targets of Cardiac HormonesTherapeutic Anti-Cancer Effects

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 9
Page: 1159-1166
Authors: David L. Vesely

Predictive Molecular Markers of Response to Epidermal Growth Factor Receptor(EGFR) Family-Targeted Therapies

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 8
Page: 799-812
Authors: Sarah Barton, Naureen Starling and Charles Swanton

Somatostatin Receptor-Targeted Anti-Cancer Therapy

Journal: Current Drug Delivery
Volume: 8,Issue: 1
Page: 2-10
Authors: Li-Chun Sun and David H. Coy

The Impact of Folate Status on the Efficacy of Colorectal Cancer Treatment

Journal: Current Drug Metabolism
Volume: 12,Issue: 10
Page: 975-984
Authors: Letizia Porcelli, Yehuda G. Assaraf, Amalia Azzariti, Angelo Paradiso, Gerrit Jansen and Godefridus J. Peters

Effective Treatment of Human Lung Cancer by Targeting Tissue Factor with a Factor VII-Targeted Photodynamic Therapy

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 9
Page: 1069-1081
Authors: J. Cheng, J. Xu, J. Duanmu, H. Zhou, C. J. Booth and Z. Hu

Efficacy and Toxicological Studies of Cremophor EL Free Alternative Paclitaxel Formulation

Journal: Current Drug Safety
Volume: 6,Issue: 5
Page: 329-338
Authors: Puneet Utreja, Subheet Jain, Subodh Yadav, K. L. Khandhuja and A. K. Tiwary

Targeting Angiogenesis for Treatment of NSCLC Brain Metastases

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 3
Page: 289-299
Authors: C. Schettino, M. A. Bareschino, A. Rossi, P. Maione, P. C. Sacco, G. Colantuoni, E. Rossi and C. Gridelli

Factors Driving the Choice of the Best Second-Line Treatment of Advanced NSCLC

Journal: Reviews on Recent Clinical Trials
Volume: 6,Issue: 1
Page: 44-51
Authors: Paolo Maione, Antonio Rossi, Maria Anna Bareschino, Paola Claudia Sacco, Clorinda Schettino, Marzia Falanga, Valentina Barbato, Rita Ambrosio and Cesare Gridelli

Epidermal Growth Factor Receptor Inhibitors: A New Prospective in the Treatment of Lung Cancer

Journal: Current Medicinal Chemistry-Anti-Cancer Agents
Volume: 4,Issue: 2
Page: 139-148
Authors: M. Tiseo, M. Loprevite and A. Ardizzoni

ErbB Antagonists Patenting: “Playing Chess with Cancer”

Journal: Recent Patents on Biotechnology
Volume: 2,Issue: 3
Page: 181-187
Authors: Sami Aifa and Ahmed Rebai

Regulatory Role of the α7nAChR in Cancer

Journal: Current Drug Targets
Volume: 13,Issue: 5
Page: 680-687
Authors: Hildegard M. Schuller

Molecular Targets of Gemcitabine Action: Rationale for Development of Novel Drugs and Drug Combinations

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 19
Page: 2811-2829
Authors: Maha Elnaggar, Elisa Giovannetti and Godefridus J. Peters

Neutrophil Elastase as a Target in Lung Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 6
Page: 565-579
Authors: Gautier Moroy, Alain J.P. Alix, Janos Sapi, William Hornebeck and Erika Bourguet

Anticancer Effects of the Organosilicon Multidrug Resistance Modulator SILA 421

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 6
Page: 663-671
Authors: Ulrike Olszewski, Robert Zeillinger, Meltem Demirel Kars, Attila Zalatnai, Jozsef Molnar and Gerhard Hamilton

Acid Ceramidase as a Chemotherapeutic Target to Overcome Resistance to the Antitumoral Effect of Choline Kinase α Inhibition

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 6
Page: 617-624
Authors: A. Ramirez de Molina, A. de la Cueva, R. Machado-Pinilla, V. Rodriguez-Fanjul, T. Gomez del Pulgar, A. Cebrian, R. Perona and J. C. Lacal


Stress Relaxation Testing of Non-Small Lung Cancer Cells Using Atomic Force Microscopy

Journal: Current Nanoscience
Volume: 8,Issue: 5
Page: 676-679
Authors: Ya Li, Jinghe Wang, Wenjie Zhai, Yu Li and Shen Dong

Tumor-Intrinsic and Tumor-Extrinsic Factors Impacting Hsp90- Targeted Therapy

Journal: Current Molecular Medicine
Volume: 12,Issue: 9
Page: 1125-1141
Authors: S.V. Alarcon, M. Mollapour, M.-J. Lee, S. Tsutsumi, S. Lee, Y.S. Kim, T. Prince, A.B. Apolo, G. Giaccone, W. Xu, L.M. Neckers and J.B. Trepel

Animal Modeling of Cancer Pathology and Studying Tumor Response to Therapy

Journal: Current Drug Targets
Volume: 13,Issue: 12
Page: 1535-1547
Authors: Simon P. Langdon

The c-Met Inhibitors: A New Class of Drugs in the Battle Against Advanced Nonsmall- Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 37
Page: 6155-6168
Authors: Assunta Sgambato, Francesca Casaluce, Paolo Maione, Antonio Rossi, Emanuela Rossi, Alba Napolitano, Giovanni Palazzolo, Maria Anna Bareschino, Clorinda Schettino, Paola Claudia Sacco, Fortunato Ciardiello and Cesare Gridelli

An Interventional Pulmonologist’s Tool: Endobronchial Ultrasound- Guided Transbronchial Needle Aspiration (EBUS-TBNA) in Thoracic Disease — An Update

Journal: Current Respiratory Medicine Reviews
Volume: 8,Issue: 5
Page: 396-408
Authors: Andrew R.L. Medford

Flavonoids and Linderone from Lindera oxyphylla and their Bioactivities

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 16,Issue: 2
Page: 160-166
Authors: Masoumeh Hosseinzadeh, A. Hamid A. Hadi, Jamaludin Mohamad, Mohammad A. Khalilzadeh, Shiau-Chuen Cheahd and Mehran Fadaeinasab

Cytotoxicity and Cell Death Mechanisms Induced by a Novel Bisnaphthalimidopropyl Derivative against the NCI-H460 non-small Lung Cancer Cell Line

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 3
Page: 414-421
Authors: Raquel T. Lima, Gemma A. Barron, Joanna A. Grabowska, Giovanna Bermano, Simranjeet Kaur, Nilanjan Roy, M. Helena Vasconcelos and Paul K.T. Lin

Impact of PLK-1 Silencing on Endothelial Cells and Cancer Cells of Diverse Histological Origin

Journal: Current Gene Therapy
Volume: 13,Issue: 3
Page: 189-201
Authors: Carla P. Gomes, Ligia C. Gomes-da-Silva, Jose S. Ramalho, Maria C.P. de Lima, Sergio Simoes and Joao N. Moreira

Synthesis, Characterization, Antimycobacterial and Anticancer Evaluation of New 1,2,4-Triazole Derivatives

Journal: Letters in Drug Design & Discovery
Volume: 11,Issue: 3
Page: 290-296
Authors: G. Cihan-Ustundag, B. Simsek, E. Ilhan and G. Capan

Advances in the Researches on the Biological Activities and Inhibitors of Phosphatidylinositol 3-kinase

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 5
Page: 673-687
Authors: Jian-Feng Tang, Qing Wen, Jian Sun, Wei-Ming Zhang and Hai-Liang Zhu

Combining Anti-Epidermal Growth Factor Receptor (EGFR) and Anti-Angiogenic Strategies in Advanced NSCLC: We Should have Known Better...

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 24
Page: 3901-3913
Authors: Massimo Di Maio, Alessandro Morabito, Maria Carmela Piccirillo, Gennaro Daniele, Pasqualina Giordano, Raffaele Costanzo, Claudia Sandomenico, Agnese Montanino, Gaetano Rocco and Francesco Perrone

Anticancer Activity of New Compounds Using Benzimidazole as a Scaffold

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 7
Page: 1003-1018
Authors: Mohd Rashid, Asif Husain, Mohammad Shaharyar and Mohd Sarafroz

Long Noncoding RNA MALAT1: Insights into its Biogenesis and Implications in Human Disease

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 34
Page: 5017-5028
Authors: Yuting Wu, Cheng Huang, Xiaoming Meng and Jun Li

Current Strategies to Overcome Resistance to ALK-Inhibitor Agents

Journal: Current Drug Metabolism
Volume: 16,Issue: 7
Page: 585-596
Authors: Francesca Simionato, Melissa Frizziero, Carmine Carbone, Giampaolo Tortora and Davide Melisi

MicroRNA-31 Inhibits Lung Adenocarcinoma Stem-Like Cells via Down-Regulation of MET-PI3K-Akt Signaling Pathway

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16,Issue: 4
Page: 501-518
Authors: Chunying Hou, Bo Sun, Yao Jiang, Ji Zheng, Nan Yang, Chao Ji, Zhen Liang, Jiaojiao Shi, Rui Zhang, Yanyong Liu, Caiying Ye and Pingping Zuo

ROS1 Kinase Inhibitors for Molecular-Targeted Therapies

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 2
Page: 142-160
Authors: M.M. Al-Sanea, A.Z. Abdelazem, B.S. Park, K.H. Yoo, T. Sim, Y.J. Kwon and S.H. Lee

Risk Factors for Lung Cancer in Never Smokers: A Recent Review Including Genetics

Journal: Current Respiratory Medicine Reviews
Volume: 12,Issue: 1
Page: 74-117
Authors: Anne Marie Quinn, William G. Newman and Philip S. Hasleton

Bioactive Secondary Metabolites from a Thai Collection of Soil and Marine-Derived Fungi of the Genera Neosartorya and Aspergillus

Journal: Current Drug Delivery
Volume: 13,Issue: 3
Page: 378-388
Authors: War War May Zin, Chadaporn Prompanya, Suradet Buttachon and Anake Kijjoa

Integrated In Silico-In Vitro Discovery of Lung Cancer-related Tumor Pyruvate Kinase M2 (PKM2) Inhibitors

Journal: Medicinal Chemistry
Volume: 12,Issue: 7
Page: 613-620
Authors: Xiangyun Ye, Yinjia Sun, Yunhua Xu, Zhiwei Chen and Shun Lu

Pax5 Re-expression in H460 Cells Treated with the Combination of Demethylating Agent and Histone Deacetylase Inhibitor is Associated with the Enhancement of P53 Binding to Pax5 Promoter Region

Journal: Current Cancer Drug Targets
Volume: 17,Issue: 2
Page: 169-176
Authors: Yuanxin Liang, Jinwu Zeng, Linda Jelicks, Shengwei Ma, Jing Liu, Jingsong Mei, Roman Perez-Soler and Yiyu Zou

Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 9
Page: 775-793
Authors: Deepa Subramaniam, Aiwu R. He, Jimmy Hwang, John Deeken, Michael Pishvaian, Marion L. Hartley and John L. Marshall

Overcoming Resistance to EGFR Inhibitors in NSCLC

Journal: Reviews on Recent Clinical Trials
Volume: 11,Issue: 2
Page: 99-105
Authors: Paolo Maione, Paola C. Sacco, Francesca Casaluce, Assunta Sgambato, Giuseppe Santabarbara, Antonio Rossi and Cesare Gridelli

Current Status and Perspectives Regarding the Therapeutic Potential of Targeting EGFR Pathway by Curcumin in Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 13
Page: 2002-2008
Authors: Mojtaba Shafiee, Elham Mohamadzade, Soudabeh ShahidSales, Samaneh Khakpouri, Mina Maftouh, Seyed Alireza Parizadeh, Seyed Mahdi Hasanian and Amir Avan

Editorial (Thematic Issue: “miRNA and Cancer; Computational and Experimental Approaches”)

Journal: Current Pharmaceutical Biotechnology
Volume: 15,Issue: 5
Page: 429-429
Authors: Yusuf Tutar

Nanoparticles of Biodegradable Polymers for Clinical Administration of Paclitaxel

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 4
Page: 413-424
Authors: Si-Shen Feng, Li Mu, Khin Yin Win and Guofeng Huang


Role of Tyrosine Kinase Inhibitors in Lung Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 5
Page: 569-575
Authors: J. Ansari, D. H. Palmer, D. W. Rea and S. A. Hussain

New Molecular Targets in the Treatment of NSCLC

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 30
Page: 5333-5343
Authors: Clorinda Schettino, Maria Anna Bareschino, Paola Claudia Sacco, Paolo Maione, Antonio Rossi, Francesca Casaluce, Assunta Sgambato and Cesare Gridelli

Farnesyltransferase Inhibitors: A Comprehensive Review Based on Quantitative Structural Analysis

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 38
Page: 4888-4923
Authors: N. S.H.N. Moorthy, S. F. Sousa, M. J. Ramos and P. A. Fernandes

“Impact of Smoking Cessation Treatment” on Lung Function and Response Rate in EGFR Mutated Patients: A Short-Term Cohort Study

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 10,Issue: 3
Page: 342-351
Authors: Aldo Pezzuto, Luciano Stumbo, Marco Russano, Pierfilippo Crucitti, Simone Scarlata, Marco Caricato and Giuseppe Tonini

Dendrimer Based Formulation of Erlotiniib HCl: Development, Characterization and In-Vitro Evaluation

Journal: Pharmaceutical Nanotechnology
Volume: 3,Issue: 4
Page: 315-321
Authors: Rachna D. Singh, Vaibhav Khare, Farnaz Yusuf, Abid Hamid, Asha Chaubey and Shashank Singh

Topotecan Is a Substrate for Multidrug Resistance Associated Protein 4

Journal: Current Drug Metabolism
Volume: 7,Issue: 1
Page: 105-118
Authors: Quan Tian, Jing Zhang, Sui Y. Chan, Theresa M. Chin Tan, Wei Duan, Min Huang, Yi Zhun Zhu, Eli Chan, Qiang Yu, Yu Qiang Nie, Paul Chi-Liu Ho, Qi Li, Ka-Yun Ng, Hong Yuan Yang, Hong Wei, Jin Song Bian and Shu Feng Zhou

Molecule of the Month

Journal: Current Topics in Medicinal Chemistry
Volume: 8,Issue: 1
Page: 62-62
Authors: Craig W. Lindsley and Ashley L. Thomas

Molecule of the Month

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 17
Page: 1753-1753
Authors: Kirk L. Stevens

Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide- binding Pocket

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 26
Page: 2702-2717
Authors: Alison Donnelly and Brian S. J. Blagg

Results 1 - 261 of 261